Cell Therapy - a Promising Research Field of Modern Medicine

ENCITEThe European Network for Cell Imaging and Tracking Expertise (ENCITE) is a four year project funded by the European Commission that started in June 2008 and consists of 29 international scientific partners from ten countries, co-ordinated by the European Institute for Biomedical Imaging Research (EIBIR).

Thanks to a strong collaboration of 26 European institutes and three from Israel with outstanding expertise in cell imaging and tracking, the consortium has the ambitious mission to develop and test new MR and optical imaging methods and biomarkers to get a more comprehensive picture of cell fate and the reaction of the immune system and to ultimately improve and further develop cell therapy for the benefit of the European patient.

After a very successful first project year, ENCITE is proud to have achieved first outstanding key results within the subjects novel imaging technologies and novel tools for cell labelling:

  • MR imaging methods for cell tracking based on iron oxides were successfully implemented, and clinical methodologies for preclinical evaluation of novel drugs were adapted and optimised.
  • Preliminary experiments were successfully carried out regarding novel tools for cell labelling and cell fate imaging (recruitment, differentiation, and cell death).

A special highlight was the successful construction of the Adenovirus TK vector. As for cell fate imaging, experiments showed that it is possible to image tumour stroma cell activation and differentiation by fluorescence intravital microscopy.

Within novel imaging technologies, the consortium is confident of reaching the overall goal to provide novel imaging technologies and post-processing tools that will enable more efficient and sensitive diagnostic and scientific tools in the field of cell therapy. The consortium is highly encouraged to facilitate new and groundbreaking developments in the field of cell-based therapies.

The main scientific results have been published in different journals as well as in scientific conferences and on the ENCITE website.

With respect to the training of staff in imaging, a particular highlight will be the 2nd ENCITE Educational Workshop in Leiden, from 21-22 May, 2010.

For further information, please visit:
http://www.encite.org

About The European Institute for Biomedical Imaging Research (EIBIR)
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company dedicated to the co-ordination of research. The network has the aim of co-ordinating and supporting the development of biomedical imaging technologies and the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease. The platform supports networking activities in research and is key to spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research. This will generate critical mass and help coordinate research into new instrumentation, new methods, concepts and technologies.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...